Pages

Tuesday, December 15, 2015

Compounding on FDA Priority List

Dec. 14 — The top priorities for the FDA's Center for Drug Evaluation and Research (CDER) in 2016 include the reauthorization of the drug user fee programs ..

No comments:

Post a Comment